 |
regorafenib |
|---|---|
| Trade Name | Stivarga |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-04 00:00:00 |
| Sponsor | Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Blvd, P. O. Box 915;Whippany, New Jersey, 07981 |
| |
regorafenib |
|---|---|
| Trade Name | Stivarga |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-04 00:00:00 |
| Sponsor | Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Blvd, P. O. Box 915;Whippany, New Jersey, 07981 |